Hans‐Jonas Meyer

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape

Macrophages in immunoregulation and therapeutics

Infective endocarditis in congenital heart disease

Hypertrophic Cardiomyopathy

Pediatric infective endocarditis in the modern era

Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.

Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.

Prevention of Bacterial Endocarditis

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease

ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2015 ESC Guidelines for the management of infective endocarditis

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma

Hypertrophic non-obstructive cardiomyopathy caused by disorder of the myofiber texture

Current clinical aspects of bacterial endocarditis in infancy, childhood, and adolescence